KARTEAN Trademark

Trademark Overview


On Monday, September 18, 2017, a trademark application was filed for KARTEAN with the United States Patent and Trademark Office. The USPTO has given the KARTEAN trademark a serial number of 79220721. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Thursday, May 20, 2021. This trademark is owned by NOVARTIS AG. The KARTEAN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical and biological preparations for medical diagnostic use; pharmaceutical and biological preparations for medical use, namely, for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system, and for the treatment of inflammatory diseases and disorders; pharmaceutical and biological preparations for medical use, namely, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological diseases and disorders; pharmaceutical and biological preparations for medical use, namely, for the prevention and treatment of ocular disorders and diseases, for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral and antib...
kartean

General Information


Serial Number79220721
Word MarkKARTEAN
Filing DateMonday, September 18, 2017
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateThursday, May 20, 2021
Registration Number5425701
Registration DateTuesday, March 20, 2018
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 2, 2018

Trademark Statements


Goods and ServicesPharmaceutical and biological preparations for medical diagnostic use; pharmaceutical and biological preparations for medical use, namely, for the prevention and treatment of diseases and disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the endocrine system, the respiratory system, the musculo-skeletal system and the genitourinary system, and for the treatment of inflammatory diseases and disorders; pharmaceutical and biological preparations for medical use, namely, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological diseases and disorders; pharmaceutical and biological preparations for medical use, namely, for the prevention and treatment of ocular disorders and diseases, for the treatment of diseases and disorders caused by bacteria, autoimmune diseases and disorders, kidney diseases and disorders, diabetes; antifungal, anti-infective, antiviral and antibiotic preparations

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeH - NOT AVAILABLE
Class Status DateThursday, May 20, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Tuesday, October 25, 2022FINAL DECISION TRANSACTION PROCESSED BY IB
Sunday, September 19, 2021REFUSAL PROCESSED BY IB
Sunday, June 6, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Sunday, June 6, 2021DEATH OF INTERNATIONAL REGISTRATION
Friday, June 8, 2018NOTIFICATION PROCESSED BY IB
Friday, April 20, 2018FINAL DISPOSITION NOTICE SENT TO IB
Friday, April 20, 2018FINAL DISPOSITION PROCESSED
Thursday, April 19, 2018GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Tuesday, March 20, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, January 2, 2018PUBLISHED FOR OPPOSITION
Wednesday, December 13, 2017NOTICE OF PUBLICATION
Friday, November 24, 2017APPLICATION FILING RECEIPT MAILED
Wednesday, November 22, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 20, 2017ASSIGNED TO EXAMINER
Monday, November 20, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, November 13, 2017LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, November 9, 2017SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB